VTE Incidence in Severe Sepsis and Septic Shock
- Conditions
- Severe Sepsis With Septic Shock
- Registration Number
- NCT02353910
- Lead Sponsor
- University of Utah
- Brief Summary
Prospective studies on the incidence of VTE during severe sepsis and septic shock remain absent, hindering efficacy assessments regarding current VTE prevention strategies in septic patients. The investigators will prospectively study consecutively enrolled ICU patients with severe sepsis and septic shock admitted at three hospitals. All patients will provide informed consent and the study will be IRB approved. VTE thromboprophylaxis, provided per standard of care and according to the patients' primary team, will be recorded for all patients. Patients will undergo bilateral lower (and upper, if a central venous catheter \[CVC\] was present) comprehensive compression ultrasonography (CUS) and will be followed for symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE) prior to discharge. The investigators will perform multivariate regression analyses to identify predictors of VTE.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 113
- ICU patients with severe sepsis and septic shock
- Admission diagnosis of acute VTE,
- age < 13 years,
- pregnancy,
- severe chronic respiratory disease,
- severe chronic liver disease (Child-Pugh Score of 11-15),
- moribund patients not expected to survive 24 hours, and
- acute myocardial infarction within 30 days.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of VTE 28 days
- Secondary Outcome Measures
Name Time Method